Renaissance Technologies - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 15 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2022$27,000
+92.9%
79,300
+152.5%
0.00%
Q4 2021$14,000
-96.4%
31,400
-94.1%
0.00%
Q2 2021$394,000
-4.6%
530,187
+27.7%
0.00%
-100.0%
Q1 2021$413,000
+358.9%
415,186
+272.5%
0.00%
Q4 2020$90,000
-38.8%
111,474
+19.6%
0.00%
Q2 2020$147,000
+88.5%
93,235
+101.1%
0.00%
Q1 2020$78,00046,3650.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q3 2020
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 81,491$116,0000.01%
NewSquare Capital LLC 62$00.00%
UBS Group AG 6,303$9,0000.00%
Sugarloaf Wealth Management, LLC 1$00.00%
OSAIC HOLDINGS, INC. 32$00.00%
Jacobi Capital Management LLC 1$00.00%
BANK OF AMERICA CORP /DE/ 39$00.00%
FLAGSHIP HARBOR ADVISORS, LLC 1$00.00%
WELLS FARGO & COMPANY/MN 32$00.00%
NORTHERN TRUST CORP 12,751$18,0000.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders